These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3841303)

  • 1. Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids.
    Holm BA; Notter RH; Finkelstein JN
    Chem Phys Lipids; 1985 Sep; 38(3):287-98. PubMed ID: 3841303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adsorption of natural lung surfactant and phospholipid extracts related to tubular myelin formation.
    Notter RH; Penney DP; Finkelstein JN; Shapiro DL
    Pediatr Res; 1986 Jan; 20(1):97-101. PubMed ID: 3753757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity.
    Holm BA; Notter RH
    J Appl Physiol (1985); 1987 Oct; 63(4):1434-42. PubMed ID: 3693177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein.
    Notter RH; Shapiro DL; Ohning B; Whitsett JA
    Chem Phys Lipids; 1987 Jun; 44(1):1-17. PubMed ID: 3607971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activity and lack of synergy of lung surfactant proteins SP-B and SP-C in interactions with phospholipids.
    Wang Z; Gurel O; Baatz JE; Notter RH
    J Lipid Res; 1996 Aug; 37(8):1749-60. PubMed ID: 8864959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additivity of protein and nonprotein inhibitors of lung surfactant activity.
    Wang Z; Notter RH
    Am J Respir Crit Care Med; 1998 Jul; 158(1):28-35. PubMed ID: 9655703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple mechanisms of lung surfactant inhibition.
    Holm BA; Wang Z; Notter RH
    Pediatr Res; 1999 Jul; 46(1):85-93. PubMed ID: 10400140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acylation of pulmonary surfactant protein-C is required for its optimal surface active interactions with phospholipids.
    Wang Z; Gurel O; Baatz JE; Notter RH
    J Biol Chem; 1996 Aug; 271(32):19104-9. PubMed ID: 8702584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: effects of dose, dispersion technique, and gestational age.
    Notter RH; Egan EA; Kwong MS; Holm BA; Shapiro DL
    Pediatr Res; 1985 Jun; 19(6):569-77. PubMed ID: 3839302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary importance of zwitterionic over anionic phospholipids in the surface-active function of calf lung surfactant extract.
    Wang Z; Gurel O; Weinbach S; Notter RH
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1049-57. PubMed ID: 9351602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic surface activity of films of lung surfactant phospholipids, hydrophobic proteins, and neutral lipids.
    Wang Z; Hall SB; Notter RH
    J Lipid Res; 1995 Jun; 36(6):1283-93. PubMed ID: 7666006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative adsorption of natural lung surfactant, extracted phospholipids, and artificial phospholipid mixtures to the air-water interface.
    Notter RH; Finkelstein JN; Taubold RD
    Chem Phys Lipids; 1983 Jul; 33(1):67-80. PubMed ID: 6688762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of different hydrophobic constituents in the adsorption of pulmonary surfactant.
    Wang Z; Hall SB; Notter RH
    J Lipid Res; 1996 Apr; 37(4):790-8. PubMed ID: 8732779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical inhibition of synthetic lung surfactants.
    Holm BA; Venkitaraman AR; Enhorning G; Notter RH
    Chem Phys Lipids; 1990 Feb; 52(3-4):243-50. PubMed ID: 2340601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface activity of a synthetic lung surfactant containing a phospholipase-resistant phosphonolipid analog of dipalmitoyl phosphatidylcholine.
    Wang Z; Schwan AL; Lairson LL; O'Donnell JS; Byrne GF; Foye A; Holm BA; Notter RH
    Am J Physiol Lung Cell Mol Physiol; 2003 Sep; 285(3):L550-9. PubMed ID: 12902318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atomic force microscopy studies of functional and dysfunctional pulmonary surfactant films, II: albumin-inhibited pulmonary surfactant films and the effect of SP-A.
    Zuo YY; Tadayyon SM; Keating E; Zhao L; Veldhuizen RA; Petersen NO; Amrein MW; Possmayer F
    Biophys J; 2008 Sep; 95(6):2779-91. PubMed ID: 18539636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pulmonary surfactant proteins SP-B and SP-C and calcium ions on the surface properties of hydrophobic fractions of lung surfactant.
    Christova Y; Enchev E; Lalchev Z
    Eur Biophys J; 1999; 28(1):59-66. PubMed ID: 9933924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Component-specific surface and physiological activity in bovine-derived lung surfactants.
    Notter RH; Wang Z; Egan EA; Holm BA
    Chem Phys Lipids; 2002 Jan; 114(1):21-34. PubMed ID: 11841823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of bovine pulmonary surfactant-associated proteins in the surface-active property of phospholipid mixtures.
    Yu SH; Possmayer F
    Biochim Biophys Acta; 1990 Oct; 1046(3):233-41. PubMed ID: 2223863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary SP-A enhances adsorption and appears to induce surface sorting of lipid extract surfactant.
    Schürch S; Possmayer F; Cheng S; Cockshutt AM
    Am J Physiol; 1992 Aug; 263(2 Pt 1):L210-8. PubMed ID: 1514646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.